Advertisement

Journal of Genetic Counseling

, Volume 23, Issue 5, pp 770–777 | Cite as

Insufficient Referral for Genetic Counseling in the Management of Hereditary Haemochromatosis in Portugal: A Study of Perceptions of Health Professionals Requesting HFE Genotyping

  • Bruna Leandro
  • Milena Paneque
  • Jorge Sequeiros
  • Graça PortoEmail author
Original Research

Abstract

There is a general consensus that HFE- related Hereditary Haemochromatosis (HFE-HH) should be diagnosed at early stages in pre-symptomatic individuals, in order to prevent the most severe consequences of iron overload. In Portugal, despite an increasing number of requests for genetic diagnosis of this rare disease, there is not a corresponding increase in requests for genetic counselling. The objective of the present study was to evaluate physicians’ main motivations for requesting HFE genotyping or genetic counselling for HFE-HH. We assessed current medical practices regarding family testing and diagnosis and discuss whether these can be improved in order to increase the effectiveness of disease prevention. Our results show there is a general lack of knowledge about the selection of patient cases that should be sent for genetic counseling or for molecular testing of HFE-HH by physicians (especially by general practitioners). The lack of family-based screening may indirectly compromise the efficiency of disease prevention in terms of early diagnosis and treatment. We concluded it is necessary to circulate more information about Hereditary Haemochromatosis among health professionals in order to improve strategies for its early diagnosis.

Keywords

Haemochromatosis HFE genotyping Genetic counseling Medical education General practitioners 

Notes

Acknowledgments

We are grateful to all participants for their time and valuable contributions to this study. This work was produced within the framework of a research seminar of the professional master course in genetic counseling of ICBAS, Universidade do Porto, and was funded in part by the Calouste Gulbenkian Foundation, through a fellowship to Bruna Leandro, and by the Portuguese Foundation for Science and Technology (FCT), through a postdoctoral fellowship to Milena Paneque (SFRH/BPD/66484/2009) and through the project PIC/IC/82785/2007. We also thank Carol Ann Harley, at the IBMC, for detailed revision of the manuscript.

Disclosure of Interest

The authors declare that they do not have any actual or potential conflict of interest.

They have full control of all primary data and they agree to allow the journal to review their data if requested.

Supplementary material

10897_2013_9681_MOESM1_ESM.docx (19 kb)
ESM 1 (DOCX 18 kb)

References

  1. Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. New England Journal of Medicine, 352, 1769–1778.CrossRefGoogle Scholar
  2. Aleman, S., Endalib, S., Stål, P., Lööf, L., Lindgren, S., Sandberg-Gertzén, H., et al. (2011). Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population. Scandinavian Journal of Gastroenterology, 46, 1118–1126.CrossRefGoogle Scholar
  3. Baars, M. J., Henneman, L., & Ten Kate, L. P. (2005a). Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genetics in Medicine, 7(9), 605–610.CrossRefGoogle Scholar
  4. Baars, M. J., Scherpbier, A. J., Schuwirth, L. W., Henneman, L., Beemer, F. A., Cobben, J. M., et al. (2005b). Deficient knowledge of genetics relevant for daily practice among medical students nearing graduation. Genetics in Medicine, 7(5), 295–301.CrossRefGoogle Scholar
  5. Burke, S., Stone, A., Bedward, J., Thomas, H., & Farndon, P. (2006). A “neglect part of the curriculum” or “of limited use”? Views on genetics training by nongenetics medical trainees and implications for delivery. Genetics in Medicine, 8, 109–115.CrossRefGoogle Scholar
  6. Cardoso, C. S., Oliveira, P., Porto, G., Oberkanins, C., Mascarenhas, M., Rodrigues, P., et al. (2001). Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the North and South of Portugal. European Journal of Human Genetics, 9, 843–848.CrossRefGoogle Scholar
  7. D’Alessio, F., Hentze, M. W., & Muckenthaler, M. U. (2012). The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. Journal of Hepatology, 57, 1052–1060.CrossRefGoogle Scholar
  8. EASL. (2010). EASLD clinical practice guidelines for HFE hemochromaosis. Journal of Hepatology, 53, 3–22.CrossRefGoogle Scholar
  9. European and UK Haemochromatosis Consortium. (2000). Diagnosis and management of haemochromatosis since the discovery of the HFE gene: a European experience. British Journal of Haematology, 108, 31–39.CrossRefGoogle Scholar
  10. Grosse, S. D., Rogowski, W. H., Ross, L. F., Cornel, M. C., Dondorp, W. J., & Khoury, M. J. (2010). Population screening for genetic disorders in the 21st century: evidence, economics, and ethics. Public Health Genomics, 13, 106–115.CrossRefGoogle Scholar
  11. Human Genetics Advisory Committee Meeting: communique. Canberra, 18 February 2010. Available at https://doi.org/www.nhmrc.gov.au/about/committees/hgac/meeting_100218.htm [Accessed 19 May 2010].
  12. King, C., & Barton, D. E. (2006). Best practice guidelines for the molecular Genetic diagnosis of type I (HFE-related) hereditary haemochromatosis. BMC Medical Genetics, 7, 81.CrossRefGoogle Scholar
  13. Liaw, S. T. (2010). Genetics and genomics in general practice. Australian Family Physician, 39(9), 689–691.PubMedGoogle Scholar
  14. Niederau, C., Fischer, R., & Purschel, A. (1996). Long-term survival in patients with hereditary hemochromatosis. Gastroenterology, 110, 1107–1119.CrossRefGoogle Scholar
  15. Phatak, P. D., Bonkovsky, H. L., & Kowdley, K. V. (2008). Hereditary hemochromatosis: time for targeted screening. Annals of Internal Medicine, 149, 270–272.CrossRefGoogle Scholar
  16. Plass, A. M., Baars, M. J., Beemer, F. A., & Ten Kate, L. P. (2002). Genetics education for non-genetic health care professionals in the Netherlands. Community Genetics, 9(4), 246–250.Google Scholar
  17. Skirton, H., Lewis, C., Kent, A., & Coviello, D. (2010). Genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe. European Journal of Human Genetics, 18, 972–977.CrossRefGoogle Scholar
  18. Speechley, M., Alter, D., Guo, H., Harrison, H., & Adams, P. C. (2012). Effect of ambiguous hemochromatosis gene test results on physician utilization. Medical Care, 50, 394–398.CrossRefGoogle Scholar
  19. Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks: Sage.Google Scholar
  20. U.S. Preventive Services Task Force. (2006). Screening for hemochromatosis: recommendation statement European. Annals of Internal Medicine, 145(3), 204–208.CrossRefGoogle Scholar
  21. Waalen, J., Nordestgaard, B. G., & Beutler, E. (2005). The penetrance of hereditary hemochromatosis. Best Practice & Research Clinical Haematology, 18(2), 203–220.CrossRefGoogle Scholar
  22. Waheed, A., Parkkila, S., Zhou, X. Y., Tomatsu, S., Tsuchihashi, Z., Feder, J. N., et al. (1997). Hereditary hemochromatosis: effects of P.CYS282TYR and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proceedings of the National Academy of Sciences of the United States of America, 94, 12384–12389.CrossRefGoogle Scholar
  23. Walsh, A., Dixon, J. L., Ramm, G. A., Hewett, D. G., Lincoln, D. J., Anderson, G. J., et al. (2006). The clinical relevance of compound heterozygosity for the P.CYS282TYR and H63D substitutions in hemochromatosis. Clinical Gastroenterology and Hepatology, 4, 1403–1410.CrossRefGoogle Scholar
  24. Whitlock, E. P., Garlitz, B. A., Harris, E. L., Beil, T. L., & Smith, P. R. (2006). Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 145, 209–223.CrossRefGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2014

Authors and Affiliations

  • Bruna Leandro
    • 1
    • 2
  • Milena Paneque
    • 1
    • 2
  • Jorge Sequeiros
    • 1
    • 2
  • Graça Porto
    • 1
    • 2
    • 3
    • 4
    Email author
  1. 1.ICBASUniversidade do PortoPortoPortugal
  2. 2.Centre for Predictive and Preventive Genetics (CGPP), IBMC – Institute for Molecular and Cell BiologyUniversidade do PortoPortoPortugal
  3. 3.Serviço de Hematologia, Hospital de Santo António, Centro Hospitalar do PortoPortoPortugal
  4. 4.Serviço de Hematologia, Centro Hospitalar do Porto - Hospital Geral de Santo AntónioPortoPortugal

Personalised recommendations